Format

Send to

Choose Destination
J Allergy Clin Immunol. 2012 Oct;130(4):845-52. doi: 10.1016/j.jaci.2012.07.010. Epub 2012 Aug 30.

Thymic stromal lymphopoietin and allergic disease.

Author information

1
Immunology Program, Benaroya Research Institute, Seattle, WA 98101, USA. sziegler@benaroyaresearch.org

Abstract

The importance of the epithelium in initiating and controlling immune responses is becoming more appreciated. For example, allergen contact first occurs at mucosal sites exposed to the external environment, such as the skin, airways, and gastrointestinal tract. This exposure leads to the production of a variety of cytokines and chemokines that are involved in driving allergic inflammatory responses. One such product is thymic stromal lymphopoietin (TSLP). Recent studies in both human subjects and murine models have implicated TSLP in the development and progression of allergic diseases. This review will highlight recent advances in the understanding of the role of TSLP in these inflammatory diseases. Importantly, these insights into TSLP's multifaceted role could potentially allow for novel therapeutic manipulations of these disorders.

PMID:
22939755
PMCID:
PMC3462264
DOI:
10.1016/j.jaci.2012.07.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center